CASEY LANGFORD: Open Payments
NPI 1093495459 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,791 in 142 payments from 29 companies in 2025. Trend: 2023 $161 · 2024 $2,079 · 2025 $3,791
Food & beverage: $3,231Travel & lodging: $560
| Company | Payments | Amount |
|---|---|---|
| ConvaTec Inc. | 7 | $965 |
| Novo Nordisk Inc | 14 | $342 |
| AstraZeneca Pharmaceuticals LP | 6 | $224 |
| ABBVIE INC. | 9 | $200 |
| Lundbeck LLC | 10 | $196 |
| Novartis Pharmaceuticals Corporation | 9 | $181 |
| Sumitomo Pharma America, Inc. | 8 | $179 |
| GlaxoSmithKline, LLC. | 9 | $175 |
| Amgen Inc. | 13 | $170 |
| Axsome Therapeutics, Inc. | 6 | $150 |
Products named: INNOVAMATRIX AC, AIRSUPRA, LEQVIO, GEMTESA, REXULTI, TRELEGY ELLIPTA, Rybelsus, Auvelity.
Industry payments across FL — which companies pay providers there.
